Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01339637 · ClinicalTrials.gov registry record
Evaluation of Low Source of Signal in SCOUT DS
A clinical trial, sponsored by VeraLight.
- Completed
- Registry status
- 196
- Enrollment target
NCT01339637: Completed study, sponsored by VeraLight.
NCT01339637 is a clinical trial that has completed, run by VeraLight. The registered enrollment target is 196 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01339637 has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).
Primary Outcome
The primary study endpoint is the relative true positive and relative true negative fractions between the SCOUT DS and FPG test for detecting abnormal glucose tolerance (2 hr OGTT value ≥ 140 mg/dL).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-10 |
What the finished NCT01339637 record still lists
NCT01339637 is an observational study that tracks outcomes without assigning an intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01339637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01339637 about?
NCT01339637 is a clinical study titled "Evaluation of Low Source of Signal in SCOUT DS". The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).
What is the current status of trial NCT01339637?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2011-04. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01339637?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia